Paper Details 
Original Abstract of the Article :
Generalized anxiety disorder (GAD) is a prevalent and very disabling anxiety disorder. First-line medications are antidepressants such as selective serotonin reuptake inhibitors (SSRIs) and selective serotonin and noradrenalin reuptake inhibitors (SNRIs). However, a substantial number of patients do...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/23438725

データ提供:米国国立医学図書館(NLM)

Beyond Antidepressants: Treating Generalized Anxiety Disorder

Generalized anxiety disorder (GAD) is a common and debilitating condition, often treated with antidepressants. This article explores alternative treatment options for GAD, like seeking out a different path in a challenging desert environment.

Expanding Therapeutic Options

The article highlights the need for new therapeutic options for GAD, particularly for patients who do not respond well to antidepressants or experience significant side effects. It's like discovering a new oasis that provides relief from the discomfort of traditional treatment methods. The article discusses potential alternatives, but emphasizes the need for further research and development.

Finding the Right Path for Anxiety Relief

This article encourages a broader perspective on GAD treatment, acknowledging that there may be multiple pathways to recovery. It's like recognizing that there's not just one desert route, but a variety of paths that can lead to a destination. This research encourages exploration and innovation in the search for effective and personalized treatment options.

Dr.Camel's Conclusion

This article calls for a more personalized approach to GAD treatment, acknowledging the limitations of existing therapies. It's like understanding that the desert landscape can change, and that finding the right route requires flexibility and exploration. This research emphasizes the need for continued investigation into new and effective treatments for this common and often challenging disorder.

Date :
  1. Date Completed n.d.
  2. Date Revised 2019-11-20
Further Info :

Pubmed ID

23438725

DOI: Digital Object Identifier

CCP-EPUB-20130204-2

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.